Sbi Securities Co., Ltd. Akero Therapeutics, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 2 shares of AKRO stock, worth $108. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2Holding current value
$108% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
193Shares Held
74.6MCall Options Held
241KPut Options Held
647K-
Wellington Management Group LLP Boston, MA7.9MShares$428 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X07.08MShares$384 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY5.92MShares$321 Million2.71% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$303 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$284 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.52B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...